BioCentury

8:00 AM GMT, Jan 17, 2011
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Results

Abraxane nab-paclitaxel: Additional Phase III data

Additional data from an open-label, international Phase III trial in 1,052 patients showed that first-line Abraxane plus carboplatin

Read the full 188 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.